Abuse potential, pharmacokinetics, pharmacodynamics, and safety of intranasally administered crushed oxycodone HCl abuse‐deterrent controlled‐release tablets in recreational opioid users-Reference-Cited by-同舟云学术

Abuse potential, pharmacokinetics, pharmacodynamics, and safety of intranasally administered crushed oxycodone HCl abuse‐deterrent controlled‐release tablets in recreational opioid users

Published:2013-12-11 Issue:4 Volume:54 Page:468-477
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Harris Stephen C.¹,Perrino Peter J.¹,Smith Ira²,Shram Megan J.³,Colucci Salvatore V.¹,Bartlett Cynthia²,Sellers Edward M.⁴

Affiliation:

1. Purdue Pharma L.P.StamfordCTUSA

2. INC Research TorontoTorontoOntarioCanada

3. Altreos Research PartnersTorontoOntarioCanada

4. DL Global PartnersTorontoOntarioCanada

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.235

Reference37 articles.

1. Abuse-Deterrent and Tamper-Resistant Opioid Formulations

2. Challenges in the Development of Prescription Opioid Abuse-deterrent Formulations

3. Route of drug use and its implications for drug effect, risk of dependence and health consequences

4. Abuse risks and routes of administration of different prescription opioid compounds and formulations

5. Tampering with Prescription Opioids: Nature and Extent of the Problem, Health Consequences, and Solutions

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review of Opioid Abuse-Deterrent Formulations: Impact and Barriers to Access;Journal of Pain Research;2024-06

2. State-level variation in distribution of oxycodone and opioid-related deaths from 2000 to 2021: an ecological study of ARCOS and CDC WONDER data in the USA;BMJ Open;2024-03

3. Evaluating the effectiveness of reformulated extended-release oxycodone with abuse-deterrent properties on reducing non-oral abuse among individuals assessed for substance abuse treatment with the Addiction Severity Index-Multimedia Version (ASI-MV);Current Medical Research and Opinion;2023-02-22

4. Analysis of State-level Variation in Distribution of Oxycodone and its Adverse Effect Profile in the US from 2000-2021;2022-09-04

5. An Evaluation of the Effect of the OxyContin Reformulation on Unintentional Fatal and Nonfatal Overdose;The Clinical Journal of Pain;2022-03-31